JCR Pharmaceuticals (JCRRF) to Release Quarterly Earnings on Wednesday

JCR Pharmaceuticals (OTCMKTS:JCRRF) will likely be announcing its resultson Wednesday, May 13th. Analysts expect the company to announce earnings of ($0.0418) per share and revenue of $57.7510 million for the quarter.

JCR Pharmaceuticals Price Performance

Shares of JCR Pharmaceuticals stock opened at $4.17 on Wednesday. JCR Pharmaceuticals has a 52 week low of $3.78 and a 52 week high of $5.00. The business’s fifty day simple moving average is $4.17 and its 200-day simple moving average is $4.38.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.

In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.